The community pharmacy model for colorectal cancer screening: Policy insights from a national programme

被引:2
|
作者
Della Valle, P. G. [1 ]
Deandrea, S. [1 ,2 ,3 ,9 ]
Battisti, F. [4 ]
Brusa, P. [5 ]
Mantellini, P. [4 ]
Mantovani, W. [6 ]
Narne, E. [7 ]
Odone, A. [1 ]
Senore, C. [8 ]
机构
[1] Univ Pavia, Pavia, Italy
[2] Pavia Hlth Protect Agcy, Pavia, Italy
[3] Directorate Gen Hlth, Milan, Lombardy, Italy
[4] Ist Studio, Prevenz & Rete Oncolog, Florence, Italy
[5] Univ Studi Torino, Dipartimento Sci & Tecnol Farmaco, Turin, Italy
[6] Azienda Provinciale Servizi Sanitari Trento, Trento, Italy
[7] Azienda Zero, Padua, Italy
[8] AOU Citt Salute & Sci Torino, Turin, Italy
[9] Univ Pavia, Dept Publ Hlth Expt & Forens Med, Pavia, Italy
来源
关键词
Screening; Community pharmacy; Colorectal cancer; National screening programme;
D O I
10.1016/j.sapharm.2023.08.009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: In Italy, a recent national project has expanded local collaboration between colorectal (CRC) screening programmes and pharmacies to the national level. Objective: The objective of this study is to provide an overview of the existing agreements between regional authorities and pharmacy owners in Italy regarding CRC screening programmes, to make internationally available the most qualifying elements of the collaboration.Methods: We analyzed the agreements, in force on 01/08/2021, arranged between the Regions and their respective pharmacy owners, describing the process phases addressed such as the faecal occult blood test pathway and supplementary activities provided by the pharmacies together with the CRC screening kit delivery. Results: Agreements were received from 18 Regions (86% of the total). The amount of money paid for each kit varies a lot, with a range from 0 to 18 EUR. The number of process phases covered by the agreements ranged from a maximum of 16 (out of 18) to a minimum of 0. The processes most frequently covered were the supply/ delivery of kits and education/awareness of CRC screening (68.8%). Less covered processes were warehouse management and awareness of other healthcare initiatives (12.5%), and delivery of preparation for intestinal cleansing (6.3%).Conclusions: Arrangements between pharmacies and CRC screening programmes in Italy vary widely and lack a unified model. Collaboration quality standards should be set at the national/international level.
引用
收藏
页码:1595 / 1601
页数:7
相关论文
共 50 条
  • [41] The effect of a screening programme on the outcome of colorectal cancer
    Suttie, S. A.
    Shaikh, I. A.
    Amin, A. I.
    Daniel, T.
    Yalamarthi, S.
    COLORECTAL DISEASE, 2012, 14 (08) : 937 - 942
  • [42] Costs of screening for colorectal cancer: An Australian programme
    Gow, J
    HEALTH ECONOMICS, 1999, 8 (06) : 531 - 540
  • [43] Colorectal Cancer Screening - Pilot's Programme
    Steele, R.
    JOURNAL OF PATHOLOGY, 2010, 222 : S10 - S10
  • [44] Pilot programme for screening perimenopausal women for cardiovascular risk from community pharmacy: MENOVASC Project
    Palazon-Palazon, Andrea
    Sanchez-Martinez, Diego Pablo
    FARMACEUTICOS COMUNITARIOS, 2023, 15 (03): : 17 - 24
  • [45] Collaborative research across community pharmacy in Ireland facilitated through the national pharmacy internship programme
    O'Leary, A.
    Grimes, T.
    Gallagher, P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (06) : 669 - 670
  • [46] POST-IMAGING COLORECTAL CANCER IN THE ENGLISH NATIONAL HEALTH SERVICE BOWEL CANCER SCREENING PROGRAMME
    Derbyshire, Edmund
    Plumb, Andrew
    Nickerson, Claire
    Moores, Billie
    Wright, Suzanne
    Morris, Eva
    Valori, Roland
    Rutter, Matt
    GUT, 2019, 68 : A189 - A190
  • [47] Navigating disparities: Insights from a colorectal cancer screening program in federally qualified community healthcare centers
    Amin, Robby
    Turner, Christopher
    Santellano, Brenda
    Odhiambo, Lorriane A.
    Fleming, Sable
    Ibrahim, Samah
    Mitchell, Katreena
    Merchant, Cynthia
    Patten, Douglas
    Desai, Koosh
    Hotz, James
    Durham, Lynn M.
    Gabram, Sheryl G. A.
    Cortes, Jorge E.
    Islam, Km Monirul
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Primary care provider perspectives on the role of community pharmacy in colorectal cancer screening: a qualitative study
    Brenner, Alison T.
    Rohweder, Catherine L.
    Wangen, Mary
    Atkins, Dana L.
    Ceballos, Rachel M.
    Correa, Sara
    Ferrari, Renee M.
    Issaka, Rachel B.
    Ittes, Annika
    Odebunmi, Olufeyisayo O.
    Reuland, Daniel S.
    Waters, Austin R.
    Wheeler, Stephanie B.
    Shah, Parth D.
    BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [49] Primary care provider perspectives on the role of community pharmacy in colorectal cancer screening: a qualitative study
    Alison T. Brenner
    Catherine L. Rohweder
    Mary Wangen
    Dana L. Atkins
    Rachel M. Ceballos
    Sara Correa
    Renée M. Ferrari
    Rachel B. Issaka
    Annika Ittes
    Olufeyisayo O. Odebunmi
    Daniel S. Reuland
    Austin R. Waters
    Stephanie B. Wheeler
    Parth D. Shah
    BMC Health Services Research, 23
  • [50] Colorectal cancer screening—insights and challenges
    Stephen P. Halloran
    Nature Reviews Gastroenterology & Hepatology, 2014, 11 : 586 - 587